- More than 30 years of domestic and international experience in the discovery, development, registration, and commercialization of chemical and biotechnology products.
- Executive leadership roles with Acumen Pharmaceuticals, Mendel Biotechnology and Monsanto, managing corporate and commercial development, negotiating contracts, drafting and executing business plans, developing intellectual property protection strategies, building and leading high performance teams.
- International experience in market analyses, product development, regulatory and public acceptance, and commercialization.
- Author of two published pharmacological research articles related to Alzheimer's Disease and the holder of eight patents or patent applications.
- All 7 Best Practices
- Pre-Meeting Discovery Process
- One-on-One Call with Expert
- Meeting Summary Report
- Post-Meeting Engagement
Linking Intellectual Property Protection to Core Business Objectives
Typically someone with legal patent experience is given responsibility for patent strategies. Those individuals are good at prosecuting patents, but actually may have no skills at developing an overarching intellectual property strategy. This is particularly the case for companies that have a portfolio of technologies that they desire to commercialize.
The two tasks, patent protection and intellectual property protection, are completely different, though the former is a component of the latter.
The heart of an effective intellectual property protection strategy is to have one person who is always asking the one, fundamental question: "How does this intellectual property support product or revenue generation for the company?"
What is needed is someone who understands the business and can identify the linkage between the business and the intellectual property. This person, then, also needs to understand patent law well enough – or work in concert with those who do – to create an overall plan to maximize revenue generation, protect the intellectual property and establish appropriate contractual boundaries with partners and researchers.